Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy
Advanced Materials · 2024
DOI: 10.1002/adma.202306248 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, 2024. Verfasst von Yi Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, P…. Hauptthemen laut MEDLINE: Autophagy, Immunotherapy, Toll-Like Receptor 9, Nanostructures. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Programs of the Ministry of Science and Technology, National Center for Nanoscience and Technology and Chinese Academy of Sciences.
Abstract (Originalsprache)
Smart nanorobots have emerged as novel drug delivery platforms in nanomedicine, potentially improving anti‐cancer efficacy and reducing side effects. In this study, an intelligent tumor microenvironment‐responsive nanorobot is developed that effectively delivers CpG payloads to Toll‐like receptor 9 (TLR9)‐positive tumors to induce autophagy‐mediated cell death for immunotherapy. The nanorobots are fabricated by co‐self‐assembly of two amphiphilic triblock polymer peptides: one containing the matrix metallopeptidase 2 (MMP2)‐cleaved GPLGVRGS motif to control the mechanical opening of the nanorobots and provide targeting capability for TLR‐9‐positive tumors and the other consisting of an arginine‐rich GRRRDRGRS sequence that can condense nuclear acid payloads through electrostatic interactions. Using multiple tumor‐bearing mouse models, it is investigated whether the intravenous injection of CpG‐loaded nanorobots could effectively deliver CpG payloads to TLR‐9‐positive tumors and elicit anti‐tumor immunity through TLR9 signaling and autophagy. Therefore, besides being a commonly used adjuvant for tumor vaccination, CpG‐loaded nanorobots can effectively reprogram the tumor immunosuppressive microenvironment and suppress tumor growth and recurrence. This nanorobot‐based CpG immunotherapy can be considered a feasible approach to induce anti‐tumor immunity, showing great therapeutic potential for the future treatment of TLR9‐positive cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST), Beijing, 100190, P. R. China.
- School of Nanoscience and Technology, University of Chinese Academy of Sciences (UCAS), Beijing, 100149, P. R. China.
- Institute of Bioengineering and Institute of Materials Science & Engineering, École Polytechnique Fédérale de Lausanne (EPFL), Lausanne, 1015, Switzerland.
- Lab of Functional and Biomedical Nanomaterials, College of Materials Science and Engineering, Qingdao University of Science and Technology (QUST), Qingdao, 266042, P. R. China.
ORCID-Profile: Yao-Xin Lin
Förderung
- National Natural Science Foundation of China
- Key Research and Development Programs of the Ministry of Science and Technology
- National Center for Nanoscience and Technology and Chinese Academy of Sciences
- Basic Research Cooperation Special Foundation of Beijing-Tianjin-Hebei
Zitieren
APA
Wang, Y., Qiao, S. L., Wang, J., Yu, M. Z., Wang, N. N., Mamuti, M., An, H. W., Lin, Y. X., & Wang, H. (2024). Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy. Advanced Materials. https://doi.org/10.1002/adma.202306248
Vancouver
Wang Y, Qiao SL, Wang J, Yu MZ, Wang NN, Mamuti M, et al. Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy. Advanced Materials. 2024. doi:10.1002/adma.202306248
BibTeX
@article{Wang2024,
author = {Wang, Yi and Qiao, Sheng-Lin and Wang, Jie and Yu, Meng-Zhen and Wang, Nan-Nan and Mamuti, Muhetaerjiang and An, Hong-Wei and Lin, Yao-Xin and Wang, Hao},
title = {Engineered CpG‐Loaded Nanorobots Drive Autophagy‐Mediated Immunity for TLR9‐Positive Cancer Therapy},
journal = {Advanced Materials},
year = {2024},
doi = {10.1002/adma.202306248}
}
EUVIMED